All Session Tracks

• Track 01 – Advancements in Computational Drug Design
  This track focuses on the latest methodologies and tools in computational drug design, emphasizing innovative approaches and technologies. Participants will explore case studies that highlight successful applications in drug discovery. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
• Track 02 – Molecular Docking Techniques and Applications
  This session will delve into various molecular docking techniques, including both rigid and flexible docking approaches. Discussions will center on the practical applications of these techniques in predicting ligand-receptor interactions. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
• Track 03 – Structure-Based Drug Design Strategies
  This track will cover the principles and practices of structure-based drug design, focusing on the integration of structural biology and computational methods. Attendees will learn about the role of 3D structures in optimizing drug candidates. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
• Track 04 – Virtual Screening and Pharmacophore Modeling
  This session will explore virtual screening methodologies and the development of pharmacophore models for identifying potential drug candidates. Participants will discuss the challenges and successes in applying these techniques in real-world scenarios. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
• Track 05 – Binding Affinity Prediction and Scoring Functions
  This track will address the computational techniques used for predicting binding affinities and the evaluation of scoring functions in molecular docking. The focus will be on improving accuracy and reliability in drug design. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
• Track 06 – Molecular Dynamics in Drug Discovery
  This session will highlight the role of molecular dynamics simulations in understanding protein-ligand interactions and drug stability. Participants will discuss how these simulations can inform lead optimization and drug design. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
• Track 07 – ADMET Prediction and Drug Metabolism
  This track will focus on the computational approaches used for predicting ADMET properties and their significance in drug development. Discussions will include methodologies for assessing drug metabolism and toxicity. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
• Track 08 – QSAR Modeling in Drug Design
  This session will explore quantitative structure-activity relationship (QSAR) modeling techniques and their applications in predicting biological activity. Participants will discuss the integration of cheminformatics in enhancing QSAR models. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
• Track 09 – In Silico Screening Techniques
  This track will cover the latest advancements in in silico screening methods for drug discovery. Emphasis will be placed on high-throughput screening and its integration with computational approaches. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
• Track 10 – Computational Pharmacology and Drug Target Identification
  This session will focus on the role of computational pharmacology in identifying and validating drug targets. Participants will explore case studies that demonstrate successful target identification using computational methods. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
• Track 11 – Innovations in Docking Algorithms
  This track will discuss recent innovations in docking algorithms and their impact on the accuracy of molecular docking studies. Participants will evaluate the effectiveness of new algorithms in various drug design applications. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure

Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.

• SDG 3
  Good Health and Well-being
• SDG 9
  Industry, Innovation and Infrastructure